The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentamin PLC Regulatory News (CEY)

Share Price Information for Centamin PLC (CEY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 125.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.20 (0.159%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 125.00
CEY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Centamin plc

5 Dec 2019 15:17

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Millennium International Management LP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Centamin plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

4 December 2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

Yes, Endeavour Mining Corporation

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary NPV (JE00B5TT1872)

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled:
(2) Cash-settled derivatives: - - 2,277,786 0.197%
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

- - 2,277,786 0.197%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit(GBP)
JE00B5TT1872 Equity Swap Reducing a short position 328,642 1.28
JE00B5TT1872 Equity Swap Reducing a short position 55,960 1.28
JE00B5TT1872 Equity Swap Reducing a short position 198,461 1.29
JE00B5TT1872 Equity Swap Reducing a short position 4,648 1.28
JE00B5TT1872 Equity Swap Reducing a short position 745,352 1.28
JE00B5TT1872 Equity Swap Increasing a short position 957 1.28
JE00B5TT1872 Equity Swap Increasing a short position 3,121 1.28
JE00B5TT1872 Equity Swap Increasing a short position 154,093 1.28
JE00B5TT1872 Equity Swap Increasing a short position 37,479 1.28
JE00B5TT1872 Equity Swap Increasing a short position 5,131 1.28
JE00B5TT1872 Equity Swap Increasing a short position 1,127 1.28
JE00B5TT1872 Equity Swap Increasing a short position 778 1.28
JE00B5TT1872 Equity Swap Increasing a short position 43,624 1.28
JE00B5TT1872 Equity Swap Increasing a short position 3,161 1.28
JE00B5TT1872 Equity Swap Increasing a short position 28,993 1.28
JE00B5TT1872 Equity Swap Increasing a short position 10,012 1.28
JE00B5TT1872 Equity Swap Increasing a short position 44,594 1.28
JE00B5TT1872 Equity Swap Increasing a short position 8,933 1.27
JE00B5TT1872 Equity Swap Increasing a short position 32,114 1.28
JE00B5TT1872 Equity Swap Increasing a short position 47,802 1.28
JE00B5TT1872 Equity Swap Reducing a short position 957 1.28
JE00B5TT1872 Equity Swap Reducing a short position 154,093 1.28
JE00B5TT1872 Equity Swap Reducing a short position 3,295 1.28
JE00B5TT1872 Equity Swap Increasing a short position 3,677 1.28
JE00B5TT1872 Equity Swap Increasing a short position 8,249 1.28
JE00B5TT1872 Equity Swap Opening a long position 6,331 1.29
JE00B5TT1872 Equity Swap Reducing a long position 3,036 1.28
JE00B5TT1872 Equity Swap Closing a long position 3,295 1.28

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry d ate Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 5 December 2019
Contact name: Milos Naumovic
Telephone number: +44 203 650 8203

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191205005577/en/

Copyright Business Wire 2019

Date   Source Headline
7th Dec 20207:00 amRNSDirector/PDMR Shareholding
2nd Dec 20207:00 amRNSUnlocking Centamin’s Potential – Market Event
2nd Dec 20207:00 amRNSOpen Pit Contract Award
25th Nov 20207:00 amRNSNOTIFICATION OF CAPITAL MARKETS EVENT
20th Nov 20207:11 amRNSNotification of Major Holding(s)
19th Nov 20204:40 pmRNSNotification of Major Holding(s)
18th Nov 20207:00 amRNSDirector Declaration
2nd Nov 20202:30 pmRNSDirector Declaration
29th Oct 20207:00 amRNSAppointment of Joint Corporate Broker
21st Oct 20207:00 amRNSQ3 2020 Report
7th Oct 20207:00 amRNSNOTICE OF DIRECTOR DEALING
6th Oct 20207:00 amRNSDirector/PDMR Shareholding
2nd Oct 20207:00 amRNSSukari Operational Update
2nd Sep 202012:00 pmRNSDirector/PDMR Shareholding
14th Aug 20207:00 amRNSNotice of New Website
4th Aug 20207:01 amRNS2020 Interim Results
4th Aug 20207:00 amRNSDividend Declaration
13th Jul 20207:00 amRNSQ2 2020 Report
7th Jul 20202:26 pmRNSNotification of Major Holding(s)
29th Jun 20202:34 pmRNSResult of 2020 Annual General Meeting
23rd Jun 20207:02 amRNS2019 Sustainability Report
23rd Jun 20207:00 amRNSNOTIFICATION OF MAJOR HOLDINGS
9th Jun 20203:58 pmRNSNotification of Major Holding(s)
8th Jun 20207:00 amRNSDIRECTOR/PDMR SHARE AWARDS
8th Jun 20207:00 amRNSDIRECTOR/PDMR SHARE AWARDS
1st Jun 20207:13 amRNSAppointment of Non-Executive Director
27th May 20207:00 amRNSNotice of AGM & Publication of 2019 Annual Report
18th May 20207:01 amRNSPayments to Governments Report
18th May 20207:00 amRNSAnnual Results for the year ended 31 December 2019
18th May 20207:00 amRNSAnnual Results for the year ended 31 December 2019
11th May 20209:00 amRNSNotification of Full Year 2019 Results
11th May 20207:00 amRNSDirector Declaration
27th Apr 20207:00 amRNSDisclosure of Rights attached to Equity Shares
21st Apr 20207:00 amRNSQuarterly Report and Dividend Declaration
20th Apr 20205:34 pmRNSNOTIFICATION OF MAJOR HOLDINGS
6th Apr 20207:01 amRNSNOTIFICATION OF MAJOR HOLDINGS
6th Apr 20207:00 amRNSDonation towards Egypt’s COVID-19 Relief Efforts
2nd Apr 20207:00 amRNSAppointment of CEO
25th Mar 20207:00 amRNSFCA Results Guidance and COVID-19 Update
24th Mar 20209:14 amRNSNotification of Major Holdings
25th Feb 20203:15 pmRNSForm 8.3 - Centamin PLC
21st Feb 20207:00 amRNSForm 8.3 - Centamin PLC
17th Feb 20207:00 amRNSForm 8.3 - Centamin PLC
7th Feb 20204:29 pmRNSForm 8.3 - Centamin PLC
4th Feb 202010:30 amRNSNotification of Major Holding(s)
30th Jan 20207:00 amRNSQ4 2019 Results
29th Jan 20207:00 amRNSForm 8.3 - Centamin PLC
28th Jan 202012:10 pmRNSNotification of Major Holding(s)
15th Jan 20203:20 pmRNSForm 8.3 - Centamin plc
15th Jan 20201:36 pmRNSForm 8.3 - Centamin plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.